Available Dosage Strengths
.25 mg | .5mg
Want to Prescribe?
Anastrozole rapid dissolving mini-tab is a rapid-dissolving sublingual or buccal tablet that delivers the aromatase inhibitor anastrozole. This compounded formulation allows for absorption through the oral mucosa, offering improved bioavailability and convenience compared to traditional oral tablets—especially for patients with difficulty swallowing or those seeking faster onset of action. Anastrozole is used in postmenopausal women with hormone receptor-positive breast cancer. [1]
Anastrozole is a selective non-steroidal aromatase inhibitor. In postmenopausal women, estrogens are mainly derived from the action of the aromatase enzyme, which converts adrenal androgens (primarily androstenedione and testosterone) to estrone and estradiol. Suppression of estrogen biosynthesis in peripheral tissues and in cancer cells can be achieved by specifically inhibiting the aromatase enzyme. Therapeutically, this inhibition results in decreased systemic estrogen levels and increased systemic testosterone levels, which is therapeutic in estrogen-dependent breast cancers and in disease states where increased testosterone is important. [1,2]
Common
Contraindications
Precautions:
Store at 20–25°C (68–77°F), away from moisture and light. Keep in the original packaging and out of reach of children. [3]
This sheet is a summary. It may not cover all possible drug information about this product. Call your doctor for medical advice and/or about side effects. You may report side effects to the FDA at 1-800-FDA-1088. A Wells Pharmacy Network pharmacist will be happy to answer any questions. For consultation, please call 1-800-622-4510.
